lobbying_activities: 2998959
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2998959 | 5a3d7add-e5af-4943-a9ef-926090e703e6 | Q2 | MAGILL ASSOCIATES, LLC | 401103511 | THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES | 2023 | second_quarter | MED | FY 2023 and FY 2024 appropriations for the development of a synthetic vaccine | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2023-07-05T12:51:01-04:00 |